Witness Project for Lung Cancer

AG
Overseen ByAna G Vielma, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Hackensack Meridian Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The long-term objective is to improve lung cancer screening uptake among screening-eligible Black adults and thereby reduce the population burden of late-stage diagnosis and mortality. The short-term objective of this study is to rigorously test the effectiveness, mechanisms, and implementation readiness of Witness Project® Lung.

Who Is on the Research Team?

LC

Lisa Carter-Bawa, PhD

Principal Investigator

Hackensack Meridian Health

Are You a Good Fit for This Trial?

This trial is for Black adults who are eligible for lung cancer screening. Specific inclusion and exclusion criteria are not detailed, but participants should be able to take part in educational programs about lung cancer screening.

Inclusion Criteria

Able to speak and understand English
I am between 50 and 80 years old.
20 pack-year smoking history
See 2 more

Exclusion Criteria

I have been diagnosed with lung cancer.
Unable to speak and understand English

What Are the Treatments Tested in This Trial?

Interventions

  • Witness Project Lung

Trial Overview

The study compares the Witness Project Lung, a specialized educational program, with a general educational program to see which better encourages eligible Black adults to get screened for lung cancer.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Witness Project LungExperimental Treatment1 Intervention
Group II: General Educational ProgramActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hackensack Meridian Health

Lead Sponsor

Trials
141
Recruited
42,900+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+